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In this study, we assessed the differences in the dose distribution of a 4 MV photon 
beam among different calculation algorithms: the Acuros XB (AXB) algorithm, 
the analytic anisotropic algorithm (AAA), and the pencil beam convolution (PBC) 
algorithm (ver. 11.0.31), in phantoms and in clinical intensity-modulated radiation 
therapy (IMRT) plans. Homogeneous and heterogeneous, including middle-, low-, 
and high-density, phantoms were combined to assess the percentage depth dose and 
lateral dose profiles among AXB, AAA, and PBC. For the phantom containing the 
low-density area, AXB was in agreement with measurement within 0.5%, while 
the greatest differences between the AAA and PBC calculations and measurement 
were 2.7% and 3.6%, respectively. AXB showed agreement with measurement 
within 2.5% at the high-density area, while AAA and PBC overestimated the dose 
by more than 4.5% and 4.0%, respectively. Furthermore, 15 IMRT plans, calculated 
using AXB, for oropharyngeal, hypopharyngeal, and laryngeal carcinomas were 
analyzed. The dose prescription was 70 Gy to 50% of the planning target volume 
(PTV70). Subsequently, each plan was recalculated using AAA and PBC while 
maintaining the AXB-calculated monitor units, leaf motion, and beam arrangement. 
Additionally, nine hypopharyngeal and laryngeal cancer patients were analyzed 
in terms of PTV70 for cartilaginous structures (PTV70_cartilage). The doses covering 
50% to PTV70 calculated by AAA and PBC were 2.1% ± 1.0% and 3.7% ± 0.8% 
significantly higher than those using AXB, respectively (p < 0.01). The increases 
in doses to PTV70_cartilage calculated by AAA and PBC relative to AXB were 3.9% 
and 5.3% on average, respectively, and were relatively greater than those in the 
entire PTV70. AXB was found to be in better agreement with measurement in phan-
toms in heterogeneous areas for the 4 MV photon beam. Considering AXB as the 
standard, AAA and PBC overestimated the IMRT dose for head and neck cancer. 
The dosimetric differences should not be ignored, particularly with cartilaginous 
structures in PTV.
PACS number: 87.55.-x, 87.55.dk, 87.55.kd 
Key words: Acuros XB algorithm, intensity-modulated radiation therapy, head and 
neck cancer, low-energy photon beam, heterogeneous media
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I. INTRODUCTION
Dose calculation accuracy is one of the most important steps in the radiation therapy treatment 
process; however, the dose calculation process is imperfect due to measurement uncertainties, 
inadequacies in beam modeling, and inherent limitations in the algorithms.
To maximize the therapeutic benefit of radiation therapy, it is essential that the estimated 
doses to tissues are delivered accurately. The human body consists of various tissues and cavi-
ties with different physical and radiological properties. Previous-generation dose calculation 
algorithms, such as the pencil beam convolution (PBC) algorithm, have not accurately calculated 
the doses for these tissue inhomogeneities. Current-generation dose calculation algorithms that 
have been used most commonly in clinical practice, such as the analytic anisotropic algorithm 
(AAA) and the convolution/superposition algorithm, enable moderate estimates of the changes 
in dose at locations at which electron disequilibrium exists.(1)
A newly released dose calculation algorithm was recently developed called the Acuros XB 
(AXB) algorithm, which explicitly solves the Linear Boltzmann Transport Equation (LBTE).
(2) LBTE is the governing equation that describes the distribution of radiation particles result-
ing from their interactions with matter. AXB directly discretizes the space, angle, and energy 
variables of the LBTE into grids and calculates the energy fluence variation of electrons and 
scattered photons in a substance. Some investigations have shown that AXB could achieve 
comparable accuracy to Monte Carlo methods, which are widely considered the gold standard 
for accurate dose calculation used in radiation therapy in phantom experiments, assuming the 
presence of homogeneous water and heterogeneous media.(3,4)
Widely differing densities are evident among the head and neck region (soft tissue, bone, 
air cavities); moreover, primary tumors often exist next to air in the oral or pharyngeal cavities 
and in some cartilaginous structures. Additionally, certain treated nodal regions are located at 
the shallow subcutaneous area in head and neck cancer. As reported by Petoukhova et al.,(5) 
the 4 MV photon beam produced a somewhat smaller underdosage effect behind air cavities 
and a faster rebuildup than the 6 MV photon beam in experiments using the larynx phantom. 
Therefore, the 4 MV photon beam could be advantageous over the 6 MV beam for avoiding 
underdosage to treatment targets located at the air/tissue interface. However, no study has 
reported on AXB using the 4 MV photon beam.
Additionally, the target volumes are surrounded by several organs at risk (OARs) in the head 
and neck region; therefore, long-term toxicities of radiation therapy are highly prevalent with 
three-dimensional conformal radiation therapy. Particularly, radiation-induced xerostomia is one 
of the most commonly reported long-term side effects of radiation therapy for head and neck 
cancers. Intensity-modulated radiation therapy (IMRT) can spare the major salivary glands and 
aid saliva flow recovery.(6) Kan et al.(7) assessed the dosimetric impact of using AXB instead of 
AAA for the treatment of nasopharyngeal carcinoma with IMRT using a 6 MV photon beam. 
However, no report has evaluated the dosimetric performance of AXB for oropharyngeal, 
hypopharyngeal or laryngeal carcinoma treated with IMRT. Kan and colleagues also stratified 
the target volumes into three groups — tissue, air, and bone targets — and evaluated the dose 
distributions to each group. In addition to this classification, assessing the dosimetric impact 
on pharyngeal cartilages should also be meaningful, because the cartilaginous structures are 
heterogeneous components of the target volume and clinically important organs that can be 
invaded by progressive primary tumors for hypopharyngeal and laryngeal carcinoma.(8)
The purpose of this study consisted of two phases. First, we assessed the differences in dose 
distribution of a 4 MV photon beam among different calculation algorithms, including the PBC, 
AAA, and AXB, using homogeneous and heterogeneous phantoms. Second, to assess the dose 
distributions and dose-volumetric data, IMRT plans for oropharyngeal, hypopharyngeal, and 
laryngeal carcinoma patients using AXB were recalculated for PBC and AAA while maintain-
ing the AXB-calculated monitor units and beam arrangement.
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II. MATERIALS AND METHODS
A.  Phantom study
We investigated the differences in dosimetric performance among AXB, AAA, and PBC using 
homogeneous water phantom and heterogeneous slab phantom for measurement. In homoge-
neous water phantom, the assigned computed tomography (CT) value was 0 Hounsfield unit 
(HU) with a physical density (ρ) of 1.0000 g/cm3 and electron density relative to water (ρ*) 
of 1.0000, corresponding to “water” as an assigned material. In heterogeneous phantom, the 
assigned CT values were averaged HU values for CT images obtained by scanning the respec-
tive phantoms. In order to verify the calculated dose distribution under a condition close to 
patient calculation, physical density and corresponding material were automatically assigned 
to the heterogeneous slabs in this study. The material composition of a given voxel in a 3D CT 
image was assigned automatically from the CT value based on our own CT calibration curve 
determined from the Gammex 467 Tissue Characterization Phantom (Gammex, Inc., Middleton, 
WI) and the material data in AXB (ver. 11) (Acuros; Varian Medical Systems, Palo Alto, CA). 
The automatic assignment of the materials in AXB includes human material such as “Air”, 
“Lung”, “Adipose Tissue”, “Muscle Skeletal”, “Cartilage”, and ”Bone”. According to range 
of CT values, there are overlapping physical density regions weighted linearly between two 
adjacent materials.
To evaluate the percentage depth dose (PDD) and lateral dose profile, the following three 
phantoms were combined: 1) a phantom representing a middle-density area (TM phantom; 
20 HU; Taisei Medical, Inc., Osaka, Japan) assigned to the mixed material of “Adipose Tissue” 
and “Muscle Skeletal” with a physical density (ρ) of 0.9895 g/cm3 and electron density relative to 
water (ρ*) of 0.9780; 2) a phantom representing a low-density area (RMI-455; 710 HU, Gammex 
Inc.) assigned to the material of “Lung” with a ρ of 0.2767 g/cm3 and ρ* of 0.2729; and 3) a 
phantom representing a high-density area (RMI-450; 920 HU; Gammex, Inc.) assigned to the 
material of “Bone” with a ρ of 1.6179 g/cm3 and ρ* of 1.5196. The phantom was the specific 
slab with or without a hole hosting an ion chamber (CC04, IBA Dosimetry, Schwarzenbruck, 
Germany). The geometries of these phantoms are shown in Fig. 1.
The measurements and dose calculations were performed using the CLINAC-6EX linear 
accelerator (Varian Medical Systems) with a 4 MV photon beam in the composite phantom 
at a source-to-surface distance of 100 cm with a gantry angle of 0°. Dose calculations were 
performed using Eclipse version 11.0.3 (Varian Medical Systems). The dose was reported by 
the dose-to-medium (Dm) mode for AXB. PDD was evaluated using a phantom with a homo-
geneous and heterogeneous layer in Figs. 1(a) and (b) for a field size of 10 × 10 cm2. Depth 
dose was measured using a small ion chamber with a sensitive volume of 0.04 cm3 (CC04; 
Fig. 1. Geometries of the (a) water phantom, (b) phantom with a heterogeneous layer, and (c) phantom with a heteroge-
neous insert (ρ indicates physical density).
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IBA Dosimetry). In order to compare calculations with dose to medium measurements, the 
stopping power ratio with the correct materials of 1.011 and 0.965 were used for the low- and 
high-density area, determined by reference to the publication by Araki.(9) We used specific slab 
phantoms with or without a hole hosting the ion chamber. The PDD curve was then generated 
by normalizing depth dose at maximum dose depth of 1.0 cm. The lateral dose profile was 
obtained using a phantom with the low- or high-density insert in Fig. 1(c) with a field size of 
10 × 10 cm2 and was normalized to the dose on the beam central axis at a depth of 10 cm. The 
lateral dose profile was measured using EDR2 film (Kodak, Rochester, NY).
B.  Planning study
B.1  Patient selection and volume definition of targets and organs at risk
The treatment plans for 15 patients who underwent simultaneous integrated boost IMRT (SIB-
IMRT) to treat oropharyngeal, hypopharyngeal, and laryngeal carcinoma in our institution 
between March and October 2013 were enrolled in the present study.
For the treatment planning, CT was performed using 100 cc iodinated contrast agent at a flow 
rate of 1 cc/sec. The scan was initiated 120 s after the start of the injection. CT was performed 
with the immobilization device in the treatment position and a slice thickness of 2.5 mm. The 
primary gross tumor volume (pGTV) and nodal gross tumor volume (nGTV) were contoured 
based on all available imaging methods, such as contrast-enhanced CT, magnetic resonance 
imaging, and 18F-fluorodeoxyglucose positron emission tomography, as well as clinical exami-
nation. A clinical target volume (CTV70) was created by adding a 5 mm margin to each GTV. 
The high-risk subclinical target volume (CTV63) was determined by adding 5–20 mm margins 
to the GTV, depending on tumor location and disease stage. Then, anatomical boundaries based 
on the microscopic invasion were edited manually. The CTV63 also included both node-positive 
areas and adjacent nodal regions. The CTV56 was defined as the remaining neck nodal areas 
considered low risk for potential microscopic spread. The planning target volumes prescribed 
for 70, 63, and 56 Gy (PTV70, PTV63, and PTV56, respectively) were created by adding a 5 mm 
margin to the CTV70, CTV63, and CTV56. PTVs were restricted to skin cropping at 2 mm from 
the surface. Surrounding critical normal structures, including the brainstem, spinal cord, parotid 
glands, mandible, and larynx, were contoured. The planning organs-at-risk volumes (PRVs) of 
the brainstem and spinal cord were outlined using a 5 mm margin for each organ (PRV_Stem, 
PRV_Cord).
B.2  Treatment planning
IMRT plans were created using a seven-field sliding window technique via Eclipse and the 
Dose Volume Optimizer version 11.0.3 (Varian Medical Systems). To avoid uncertainties in oral 
reproducibility and metal artifacts in teeth, we used typical gantry angles of 80°, 120°, 150°, 
180°, 210°, 240°, and 280°. All treatment plans were generated using 4 MV photon beams from 
CLINAC-6EX with a Millennium 120 multileaf collimator.
The dose prescription was 70 Gy in 35 fractions (2 Gy per fraction) to 50% of the PTV70. The 
clinical objectives for the optimization are shown in Table 1. Dose calculations were performed 
using AXB version 11.0.31 with a heterogeneity correction and 2.5 mm grid resolution. Dose 
calculations were made in the Dm mode. The material substances were allocated automatically 
using the predetermined material table (ver. 11.0). Subsequently, each plan was recalculated 
using AAA and PBC version 11.0.31 with heterogeneity correction and the same monitor units 
and leaf motions as the plan using AXB.
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B.3  Dosimetric evaluation
The following dose-volumetric data calculated using AXB, AAA, and PBC were compared 
with the PTVs: the doses covering 50% volumes (D50), minimum doses represented by doses 
covering 98% volumes (D98), and maximum doses represented by doses covering at least 2% 
volumes (D2). The homogeneity index (HI) for the PTV70 was calculated as the ratio (D2 - D98)/
D50 to evaluate target dose homogeneity.
In addition, nine hypopharyngeal and laryngeal cancer patients were analyzed in terms 
of the PTV70 for the hyoid bone, thyroid, and cricoid cartilages (PTV70_cartilage), which are 
heterogeneous components of the PTV70 and clinically important organs that can be invaded 
by progressed primary tumors.(8) Cartilaginous structures in PTV70 were first delineated by 
autosegmentation using the CT ranger tool with range of 120–3000 HU, with processing in 3D 
mode. The corresponding materials were “Cartilage” and “Bone” for 120 HU, and “Bone” for 
3000 HU. Thus, there were overlapping physical density regions for two adjacent materials. 
Then, the contours were modified manually according to the patient’s anatomy by a radiation 
oncologist. The means and standard deviations (SDs) of CT values were measured to evaluate 
variations in contouring cartilaginous structures. We also created PTV70_c_edge and PTV70_a_edge 
by generating a shell via a 2 mm expansion of the cartilaginous structures and air cavity, respec-
tively, using the autosegmentation tool, to evaluate the dose near the cartilage/tissue and air/
tissue interfaces, respectively. Examples of the structures are shown in Fig. 2.
Clinically relevant dose-volumetric data for the OARs were compared. The doses received in 
volumes of at least 2 cc (D2cc) to the brainstem and spinal cord were reported. Those volumes 
receiving 30 Gy (V30Gy) and the mean doses to the parotid glands were reported, as were the 
mean dose differences to the larynx in oropharyngeal cancer patients.
To determine the statistical significance of the observed differences, two-sided paired t-tests 
were used. A p-value less than 0.05 was deemed to indicate statistical significance.
 
Table 1. Clinical objectives for the optimization.
 Structure Index Per Protocol Acceptable Variation
 PTV70 D50 =100% 98%–103%
  D98 >93% >90%
  D2 <105% <115%
 PTV63 
* D90 =100%  >97% 
  D50 <105%  <108% 
 PTV56 
† D90 = 100% >97%
  D50 <105%  <108% 
 CTV70 D95 >100% >98%
 CTV63 D95 >100%  >98%
 CTV56 D95 >100% >98%
 GTV D95 >100% >98% 
 PRV_Stem D2cc <54 Gy <60 Gy
 Brainstem Maximum dose <54 Gy <60 Gy
 PRV_Cord D2cc <45 Gy <50 Gy
 Spinal cord Maximum dose <45 Gy <50 Gy
 Lt. Parotid V30Gy <50% 
 Rt. Parotid V30Gy <50% 
* The PTV63 index percentages are calculated based on a prescribed dose of 63 Gy.† The PTV56 index percentages are calculated based on a prescribed dose of 56 Gy.
DX = the dose covering X% volumes; D2cc = the dose received in a volume of at least 2 cc; V30Gy = volume receiving 
30 Gy; Lt. = left; Rt. = right.
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III. RESULTS 
A.  Phantom study
PDD values on the homogenous and heterogeneous phantoms are shown in Fig. 3. For the homo-
geneous phantom, each algorithm was in agreement with measurement within 1.5%, particularly 
AXB and AAA, which were within 1.0%. Additionally, regarding the phantom containing the 
low-density area, the dose calculated using AXB showed agreement with measurement within 
0.5% at the low-density area and within 1.5% at the rebuildup area. The greatest differences 
between AAA and PBC calculations and measurement were 2.7% and 3.6%, respectively, in 
the low-density area. AAA and PBC overestimated the dose distribution by more than 5.5% 
and 3.5%, respectively, at the rebuildup area. For the phantom containing the high-density 
area, the dose calculated using AXB was in agreement with measurement within 2.5% at the 
high-density area, but was overestimated at the high-density/tissue interface, with a difference 
of 3.5%. AAA and PBC overestimated the dose distribution in the high-density area by more 
than 4.5% and 4.0%, respectively.
Lateral dose profiles are shown in Fig. 4. With the low-density phantom, the greatest dif-
ferences obtained near the boundary (off-center distance of x = 0.8 cm) were 0.4%, 2.9%, and 
1.2% for AXB, AAA, and PBC, respectively. Additionally, the greatest differences obtained near 
the boundary (off-center distance of x = 0.8 cm) were 0.3%, 3.4%, and 1.3% for AXB, AAA, 
and PBC, respectively, in the high-density phantom. The averaged doses in the high-density 
area (from a 2.0 to 4.0 cm off-center distance) calculated by AXB, AAA, and PBC were 1.5%, 
5.3%, and 6.7% greater than the measurement dose, respectively.
Fig. 2. An example of the axial image of a hypopharyngeal cancer patient indicating the structure of (a) PTV70, 
(b) PTV70_cartilage, (c) PTV70_c_edge, and (d) PTV70_a_edge.
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Fig. 3. PDD of 4 MV photon beams in the (a) water phantom, (b) low-density phantom, and (c) high-density phantom. 
Differences are represented as PDD (calculation) - PDD (measurement).
Fig. 4. Lateral dose profile of 4 MV photon beams in the (a) low-density phantom and (b) high-density phantom. Differences 
are represented as PDD (calculation) - PDD (measurement).
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B.  Planning study
All of the treatment plans calculated by AXB were per protocol or at least acceptable for the 
dose-volume constraints of our protocol. The dose per fraction to the PTV70 was 2 Gy. The 
averaged total number of monitor units was 1269 ± 137.1 (range, 1037–1534) per fraction.
Table 2 summarizes the averaged dose-volumetric data of the PTVs for the 15 patients. The 
D50 to PTV70 calculated using AAA and PBC were 2.1% ± 1.0% and 3.7% ± 0.8% higher, 
respectively, than those using AXB significantly (p < 0.01). The D50 to PTV63 calculated using 
AAA and PBC were 1.8% ± 1.1% and 3.4% ± 0.6% significantly higher, respectively, than 
those using AXB (p < 0.01). The D98 to PTV63 estimated using AAA was also significantly 
higher than that using AXB, whereas no significant difference was found in the D98 to PTV63 
between PBC and AXB estimates.
The mean ± SDs of CT value in cartilaginous structures ranged from 179 ± 124 to 319 ± 
209 HU (corresponding ρ ranged from 1.1269 to 1.2199 g/cm3). The SDs ranged from 124 to 
209 HU. The minimum and maximum of mean ± SDs of CT value was 55 and 528 HU, respec-
tively (corresponding ρ ranged from 1.0724 to 1.3736 g/cm3). The corresponding materials 
were “Muscle Skeletal” and “Cartilage” for 55 HU, and “Cartilage” and “Bone” for 528 HU. 
The averaged dose-volumetric data of cartilaginous structures and air in PTV70 (PTV70_cartilage, 
PTV70_c_edge, and PTV70_a_edge) for nine patients with hypopharyngeal and laryngeal carcinoma 
are shown in Table 3. The D50 calculated by AAA was 3.9% higher for PTV70_cartilage than that 
by AXB, and the D50 calculated by PBC was 5.3% higher than that by AXB. The dose increase 
to PTV70_cartilage calculated by AAA and PBC was greater than that in the entire PTV70. For the 
PTV70_c_edge, the D50 values calculated by AAA and PBC were higher than those by AXB, and the 
differences were somewhat greater than the difference in the entire PTV70. For the PTV70_a_edge, 
the difference between AAA and AXB was smaller than that in the PTV70. Differences in PBC 
from AXB showed a similar trend. The averaged dose-volumetric histograms of nine patients for 
the PTV70, PTV70_caritlage, PTV70_c_edge, and PTV70_a_edge, calculated using the three algorithms, 
are shown in Fig. 5. The dose differences between PTV70 and PTV70_caritlage or PTV70_c_edge 
were emphasized in AAA and PBC. Figure 6 shows the dose difference distributions between 
(a) AXB and AAA and (b) AXB and PBC of the axial slice of the thyroid cartilage level in a 
representative case. Their line profiles are also shown in Fig. 6(c). In particular, AAA and PBC 
overestimated the dose to the thyroid cartilage, compared with AXB.
Table 4 summarizes the averaged dose-volumetric data to OARs. Using AAA and PBC, 
the averaged differences of D2cc for PRV_Stem were 1.3 Gy and 1.6 Gy higher and those for 
PRV_Cord were 1.8 Gy and 2.6 Gy higher, respectively, than that using AXB. Little increase 
was found in the mean dose to the parotid area and volume of V30Gy estimated using AAA and 
PBC compared with AXB.
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Fig. 5. Averaged dose-volumetric histograms of nine patients calculated using the (a) Acuros XB (AXB) algorithm, 
(b) analytic anisotropic algorithm (AAA), and (c) pencil beam convolution (PBC) algorithm. The graphs indicate PTV70, 
PTV70_cartilage, PTV70_c_edge, and PTV70_a_edge.
Fig. 6. Representative dose differences among AXB, AAA, and PBC: (a) AAA - AXB, (b) PBC - AXB. Upper and lower 
dose limits show 5% of the prescription dose. Line profiles (c) are indicated by the red arrow in (a) and (b). The gray area 
in (c) indicates the range of PTV70_cartilage, PTV70_c_edge, and PTV70_a_edge.
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IV. DISCUSSION
Some reports have shown that AXB could achieve compa-
rable accuracy to that using Monte Carlo methods, which 
have been considered the gold standard for accurate dose 
calculation.(3,4) Kroon et al.(10) compared the PDD using 
AXB for a 6 MV photon beam on a phantom containing the 
low-density area and showed that the AXB was acceptably 
consistent with measurement. In our study, AXB was found 
to be in better agreement with measurement compared with 
AAA or PBC in phantoms including low- or high-density 
areas for a 4 MV photon beam. The high-density material 
in the heterogeneous phantom was assigned to “Bone” and 
not “Cartilage.” However, AXB was in agreement with the 
measurement, to within 1.0% with the homogenous water 
phantom (ρ = 1.0000 g/cm3), and within 2.5% in a high-
density area of the heterogeneous phantom (ρ = 1.6179 g/
cm3), and within 3.5% at the interface. From these results, 
the dosimetric accuracy of AXB in the cartilaginous struc-
tures’ density range calculated from our own CT calibration 
curve (1.072 ≤ ρ ≤ 1.374 g/cm3 from our results) can be 
estimated to be as high as that in high density. Thus, assess-
ment of the dose distributions calculated using AXB even 
for a 4 MV photon beam is appropriate for clinical planning, 
except for the high-density/tissue interface.
Several investigations have been conducted on the 
clinical impact of AXB for various sites.(7,10,11) They com-
pared the dose distributions calculated by AXB with those 
by AAA in IMRT or volumetric-modulated arc therapy 
(VMAT) using 6 or 15 MV photon beams for lung cancer 
or nasopharyngeal carcinoma. Kan et al.(7) reported that 
the mean and minimum doses to the PTV70 calculated by 
AXB were lower than those by AAA for nasopharyngeal 
carcinoma. Our results using a 4 MV photon beam were 
consistent with their results. The findings of the current 
study indicated that the mean dose to the PTV70 was 
escalated naturally by 2.1%–3.7% if we maintained the 
original dose prescriptions and dose-volume constraints in 
the switch from AAA or PBC to AXB. Although increas-
ing the dose to the PTV may improve the tumor control, 
the dose increase to pharyngeal mucosa, muscle, and skin 
inside the PTV may cause unintentional toxicities. For the 
reasons mentioned above, care should be taken regarding 
the radiation-induced toxicity levels after switching the 
dose calculation algorithm.
Dosimetric evaluation of cartilaginous structures 
deserves careful attention for hypopharyngeal and laryngeal 
carcinomas. The dose differences between AAA or PBC 
and AXB were emphasized in cartilaginous structures of 
the PTV70. Relative to AXB, AAA and PBC overestimated 
the dose in cartilaginous structures (Fig. 5). When calculat-
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pay attention to the decrease in the doses to cartilaginous structures, particularly for T4 of 
hypopharyngeal tumors and T3 and T4 of laryngeal tumors. Tumors of these stages macroscopi-
cally invade thyroid or cricoid cartilage or hyoid bone, and microscopic invasion is considered 
clinically to spread throughout the entire cartilage. Thus, it is preferable in those patients with 
advanced stage to ensure the radiation doses to the cartilaginous structures without increasing 
their risk of developing cartilage necrosis.
Regarding the dosimetric effects on tissues surrounding the cartilaginous structures, the 
differences between AXB and AAA or PBC were slightly higher than that in the entire PTV70. 
However, our phantom study showed that some dose calculation errors were observed even 
when using AXB at a high-density/tissue interface; thus, accurate evaluation of PTV70_c_edge 
was difficult in the present study.
The entire cartilaginous structure is not mapped to the material of “Cartilage” in AXB. 
Cartilaginous structures were assigned automatically not only to “Cartilage”, but also “Bone”, 
“Muscle Skeletal”, and their mixed materials by AXB. The mixed material might make it difficult 
to clarify the dose calculation accuracy in AXB. However, in the clinical situation, we do not 
assign the cartilaginous structure to pure “Cartilage” material manually. Even when the tumor 
invades cartilaginous structures macroscopically and the cartilaginous structures are replaced 
with tumor, the CT value may still differ from that of “Cartilage.” Moreover, if a tumor invades 
a cartilaginous structure microscopically, the cartilaginous tissue may not be destroyed and the 
CT value may be maintained similar to that of “Cartilage.” Because of the complex material 
components in cartilaginous structures, this research is appropriate for the clinical situation. 
Furthermore, the variations in cartilaginous structures showed that the segmentation accuracy 
of cartilaginous structures was sufficient to evaluate dose distributions in the present study.
Regarding the dose effect of the tissue surrounding the air cavity, even though AAA over-
estimated the dose by more than 5.5% in the rebuildup area in the phantom experiment, the 
dose difference in the air/tissue surface calculated using AAA and AXB was comparable to that 
in the entire PTV in the clinical IMRT plan. Two possible explanations exist. First, multifield 
irradiation might reduce the overestimation of AAA. Kan et al.(7) reported that the difference 
between the doses to air calculated using AAA and AXB decreased as the number of fields 
increased. They stated that part of the dose reduction from each single field was compensated 
by the increase in the out-of-field doses from other fields coming from different directions. 
Second, there were few beams that reached a tumor via air. The anterior part of the laryngeal 
cavity rarely included the PTV70 for early T stage hypopharyngeal carcinoma, because we used 
gantry angles from only the lateral and dorsal directions to avoid oral reproducibility and metal 
artifact uncertainties.
In the current study, we created an IMRT plan using AXB and then recalculated the dose 
distributions using AAA and PBC. When applying a new calculation algorithm, the dose distri-
bution calculated using the new algorithm should be compared with that recalculated using the 
previous algorithm. Thereafter, a reconsideration of the conventional dose-volume constraints 
will be required in inverse planning, such as in IMRT or VMAT planning, to avoid overdos-
age to the targets. The appropriateness of switching the dose calculation algorithm should be 
validated carefully from a clinical viewpoint.
 
V. CONCLUSIONS
In this study, we demonstrated that AXB showed good agreement in measurements with phan-
toms containing low- and high-density areas for a 4 MV photon beam. Relative to AXB as the 
standard, AAA and PBC overestimated the dose in IMRT for oropharyngeal, hypopharyngeal, 
and laryngeal carcinomas. The differences should not be ignored, particularly with cartilaginous 
structures in the PTV70; thus, radiation oncologists should pay close attention to those cases 
with invasion to cartilaginous structures.
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